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Abstract
Abnormal amplification of centrosomes could lead to improper chromosome segregation and aneuploidy and is implicated
in cancer development. Here, we demonstrate that Axin, a scaffolding protein in Wnt signaling, is phosphorylated by PLK1
during mitosis. Phosphorylation of Axin Ser-157 by PLK1 abolished Axin association with c-tubulin, while substitution of Ser-
157 with alanine exhibited sustained interaction with c-tubulin. In addition, overexpression of Axin-S157A significantly
increased the number of cells with multi-centrosomes. These results suggest that the phosphorylation status of Axin,
mediated by PLK1, dynamically regulates its association with c-tubulin and centrosome formation and segregation.
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Introduction
Centrosome defects are implicated as a primary cause of
chromosomal instability and aneuploidy in cancer development
[1–3]. Abnormal increase in the number of centrosome can
adversely affect spindle function and cytokinesis, leading to the
formation of multi-polar spindles that promote chromosome mis-
segregation and polyploidy, and ultimately genetic instability [4,5].
Polo-like kinases (PLK) play key roles during multiple stages of
mitosis, from prophase to cytokinesis [6,7]. Endogenous protein
levels of PLK1 are up-regulated during late G2 and M phases,
where it appears to regulate the mitotic processes by phosphor-
ylating a series of substrates including Cdc25C and ROCK2 [8–
10]. Overexpression of PLK1 in tumors is frequently associated
with DNA aneuploidy and centrosome amplification. Conversely,
knockdown of PLK1 by small interference RNAs (siRNAs)
suppresses centrosome amplification [11,12].
Axin, a negative regulator of Wnt signaling, is a versatile
scaffold protein, involved in multiple signaling pathways including
the JNK MAP kinase cascade, and p53 signaling in DNA damage
response [13–15]. Moreover, Axin is found to be present on the
centrosome and along the mitotic spindle, which is regulated by
Aurora kinases [16]. The co-localization between Axin and
centrosome was also identified in Xenopus and this localization
requires the c-terminal region of Axin that includes a DIX domain
[17]. In addition, Axin2, another member of the Axin protein
family, was also shown to co-localize with the mitotic spindles of
colon cancer cells [18]. The centrosomal localization of Axin is
likely dependent on the association between Axin and c-tubulin as
knockdown of Axin affects the proper localization of c-tubulin to
the centrosome and compromises the centrosomal microtubule
nucleation activity after nocodazole treatment [19]. On the other
hand, overexpression of Axin facilitates multinuclear giant cell
formation in the gastric cancer cell line AGS [20]. Ectopically
expressed Axin alters the distribution of PLK1 and GSK3b, and
renders the cells able to bypass the cytokinesis failure mediated by
Aurora inhibition through an aberrant actin-based cytokinesis
[16].
In this study, we identify that Axin is a direct phosphorylation
substrate of PLK1. The critical residue for PLK1 phosphorylation
was mapped to residue Ser-157 of mouse Axin, phosphorylation of
which leads to dissociation between Axin and c-tubulin. In
addition, we also demonstrate that ectopic expression of Axin
S157A mutant results in sustained interaction of Axin and c-
tubulin, and leads to abnormal multi-centrosome formation. Our
study thus provides strong evidence for the link between Axin and
centrosome formation, and will shed new light on the causes of
tumorigenesis resulting from dysregulated mitosis.
Results
1. Phosphorylation of Axin by PLK1
Axin is reported to localize at the mitotic spindle throughout the
mitotic phase when PLK1 kinase activity accumulates to
maximum during the cell cycle. We found that both Axin and
Axin2 interact with PLK1 (Figure 1A, B) [16,18]. When exploring
biochemical consequence of the interaction between PLK1 and
Axin, we found that Axin displayed an up-shift in mobility on the
SDS-PAGE gel when co-expressed with PLK1, whereas Axin2 did
not show such a mobility shift (Figure 1A). We then immunopre-
cipitated Axin from cells co-expressing both Axin and PLK1 and
subjected the immunoprecipitates to treatment with or without calf
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intestinal phosphatase (CIP). In the untreated group, Axin co-
expressed with wild-type (WT) PLK1 but not kinase dead K82M
mutant (DN) PLK1 had a slower mobility on the gel, compared to
that co-expressed with a control vector. After CIP treatment, the
mobility difference between the three samples was abolished
(Figure 1C), indicating that the mobility shift of Axin is caused by
phosphorylation. As PLK1 is predominantly expressed in the late-
G2 and M-phase [6], HeLa cells were synchronized and arrested
in the M-phase with thymidine-nocodazole treatment to elevate
PLK1 protein levels or in the early-S-phase with double-thymidine
treatment as a control. An up-shift in mobility of the immuno-
precipitated endogenous Axin from the M-phase cells compared to
the untreated or early-S-phase cells was observed, which
disappeared after the CIP treatment (Figure 1D). Either knock-
down of PLK1 by siRNA or treatment with PLK1 inhibitor
abolished the mobility shift of Axin in the M-phase arrested cells
without affecting Axin in untreated or the early-S-phase arrested
cells (Figure 1E, F). Up-shift of Axin was also observed in HeLa
cells that progressed synchronously from early-S-phase to the next
G1-phase (Figure 1G), indicating that PLK1 is the kinase that
phosphorylates Axin during M-phase.
2. Identification of PLK1 phosphorylation sites on Axin
In order to locate the exact amino acid residue(s) of Axin that is
phosphorylated by PLK1, we utilized mass spectrometric analysis
to examine HA-Axin samples immunoprecipitated from
HEK293T cells co-expressing PLK1-WT or PLK1-DN. The
residue Ser-157 of Axin was found to be phosphorylated only in
cells co-expressing PLK1-WT but not PLK1-DN (Figure 2A).
However, S157A mutant retained mobility shift when co-
expressed with PLK1 (Figure 2B). We then continued to substitute
a series of other potentially phosphorylated serine or threonine
residues with alanine. When Ser-157, Ser-490 and Ser-798 (Axin-
3SA) were simultaneously mutated, the mobility up-shift no longer
occurred, while single mutations of Ser-490 and Ser-798 or double
mutation of these two sites did not abrogate the mobility shift
(Figure 2B). An in vitro kinase assay using wild-type or serine-to-
alanine mutants of Axin as substrates for PLK1 was performed to
test if these sites are direct PLK1 phosphorylation sites. As shown
in Figure 2C, Axin mutants with Ser-157 altered abolished in vitro
phosphorylation by PLK1, but S490A and S798A mutations have
no such an effect. These results suggest that only Ser-157 is the
direct phosphorylation site for PLK1, while Ser-490 and Ser-798
Figure 1. Axin phosphorylation by PLK1. (A) Total cell lysates (TCL) from cells expressing Axin or Axin2 with PLK1 or empty vector in HEK293T
cells were analyzed by immunoblotting as indicated. (B) Axin interacts with PLK1 at its endogenous level. The HeLa cell lysates were
immunoprecipitated with anti-Axin, mouse anti-PLK1 or control IgGs, respectively, followed by immunoblotting as indicated. (C) HA-Axin
immunoprecipitates were subjected to CIP treatment and immunoblotting as indicated. (D) HeLa cells were mock treated or arrested in M-phase or
early-S-phase by treatment with double-thymidine or thymidine-nocodazole. Axin immunoprecipitates were treated with CIP, followed by
immunoblotting. (E, F) TCLs from cells expressing siRNA against PLK1 (E) or were treated with 50 nM of PLK1 inhibitor 10 h before harvest (F) were
analyzed by immunoblotting as indicated. (G) PLK1 phosphorylation on Axin at G2/M transition. HeLa cells were synchronized by double-thymidine
block and released in fresh medium for indicated times. TCLs were analyzed by western blot and probed with antibodies as indicated.
doi:10.1371/journal.pone.0049184.g001
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are not directly phosphorylated by PLK1 but through other PLK1
kinase activity dependent events.
3. Phosphorylation status of Axin determines its affinity
for c-tubulin
It was previously reported that Axin but not Axin2 can form a
complex with c-tubulin [19]. Coincidently, we also found that
Axin but not Axin2 shows mobility shift when co-expressed with
PLK1 (Figure 1A). To test the possibility that the selective
phosphorylation on Axin may have a role in regulating Axin-c-
tubulin interaction, we first verified interaction between endoge-
nous Axin and c-tubulin in HEK293T cells (Figure 3A). Co-
expression of PLK1-WT but not PLK1-DN reduced the amount
of c-tubulin co-immunoprecipitated with Axin, while Axin-S157A
and Axin-3SA showed a sustained interaction between Axin and
c-tubulin, neglecting the effect caused by co-expression of PLK1-
Figure 2. Identification of PLK1 phosphorylation sites on Axin. (A) Mass spectrometry analysis using Axin immunoprecipitates shows that
Ser-157 in Axin is one of the phosphorylation sites of PLK1. Upper panel: HA-Axin was immunoprecipitated from cells co-expressing PLK1-WT; lower
panel: from cells co-expressing PLK1-DN. (B) Axin-3SA mutant no longer displays its mobility shift when co-expressed with PLK1. HA-tagged Axin-WT,
Axin-S157A, Axin-3SA, Axin-S490A, and Axin-S798A, Axin-S490A/S798A mutants are co-expressed with Myc-PLK1-WT or Myc-PLK1-DN in HEK293T
cells, respectively. At 24 h post-transfection, cell lysates were subjected to immunoblotting as indicated. (C) Phosphorylation of Axin by PLK1 in vitro.
HEK293T cells were transfected with HA-Axin-WT or HA-Axin serine-to-alanine mutants, and cell extracts were immunoprecipitated with HA-antibody.
The immunocomplexes were incubated with purified FLAG-PLK-WT or FLAG-PLK1-DN in the presence of [c-32P] ATP for the kinase assay. Following
the assay, samples were subjected to Coomassie Blue staining and autoradiography as indicated.
doi:10.1371/journal.pone.0049184.g002
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WT (Figure 3B). Consistent with our conclusion that Ser-490 and
Ser-798 are not directly phosphorylated by PLK1 which is drawn
from the in vitro kinase assay, the Myc-Axin-S490/798A double-
point mutant behaved similarly to the wild-type Axin in c-tubulin
binding (Figure 3B). These results suggest that Ser-157 phosphor-
ylation of Axin by PLK1 alone is sufficient to regulate Axin-c-
tubulin association.
The subcellular localization of Axin, PLK1 and c-tubulin was
also investigated by immunostaining in HeLa cells (Figure 4A and
Figure S1). Consistent with the co-immunoprecipitation results,
the co-localization rate between GFP-Axin and endogenous c-
tubulin at c-tubulin positive foci was greatly compromised by co-
expression of PLK1-WT but not PLK1-DN (21.26% vs. 87.71%,
Figure 4B and Figure S2), while PLK1-WT co-expression did not
disrupt the co-localization between the endogenous c-tubulin and
the GFP-Axin-S157A mutant. We further investigated the effect of
PLK1 overexpression on centrosome localization of endogenous
Axin. As shown in Figure 4C and D, PLK1-WT reduced Axin-c-
tubulin co-localization rate at the centrosome region to 58.2%
compared to that in control cells (81.4%) or PLK1-DN expressing
cells (77.1%), suggesting a PLK1 kinase activity dependent
regulation of Axin and c-tubulin association and co-localization.
4. Axin Ser-157 mutation causes multi-centrosome
formation
To explore functional significance of Axin phosphorylation by
PLK1, we transfected GFP-Axin-S157A into HeLa cells. We
found that overexpression of Axin-S157A mutant led to an
increased ratio of multi-centrosome containing mitotic cells from
2.3% (control) to 21.2% (Axin-S157A transfected) as indicated by
the centrosome marker pericentrin (Figure 5A, B). We also
quantified the percentage of multi-centrosome-containing mitotic
cells in the background of GFP-Axin-WT overexpression. The
results show that overexpression of GFP-Axin-WT induced only
6.3% of mitotic cells with multi-centrosome, indicating that the
PLK1 phosphorylation of Axin is important for proper centrosome
duplication.
As shown in Figure 4A, multiple c-tubulin foci were observed in
Axin and PLK1 coexpressing cells. To investigate whether these
foci are extra-centrosomes, we examined centrosome numbers in
interphase cells overexpressing Axin or its S157A mutant.
Consistent with the observation that Axin are largely unpho-
sphorylated by PLK1 in non-mitotic cells (Figure 1, E to G), the
centrosome numbers in interphase cells are not significantly
altered by Axin-S157A overexpression (Figure 5B, C). Similar to
Axin-WT expressing mitotic cells, a moderate increase of
pericentrin positive foci was observed in Axin-WT (10.0%) or
Axin-S157A (11.8%) expressing interphase cells. These extra-
centrosomes could be partly derived from the mitotic cells with
altered centrosome numbers. To investigate the effect of multi-
centrosomes on the process of mitosis, HeLa cells were synchro-
nized at metaphase and released at different time points.
Chromosomes began to segregate in 20 min in control cells,
whereas chromosome segregation in cells overexpressing Axin-
S157A was postponed to about 2 h after release, which indicates
that the multi-centrosome phenotype leads to partial block of
mitosis (Figure 5D).
Discussion
In the present study, we have provided evidence to indicate that
Axin is a substrate for the protein kinase PLK1 that localizes to
centrosome and is required for proper chromosome separation
during mitosis. Combined results from mass spectrometric analysis
and mutational studies revealed that Ser-157 of Axin is directly
phosphorylated by PLK1. Through co-immunoprecipitation
experiments, we found that c-tubulin preferentially associates
with unphosphorylated Axin. Importantly, mutation of Ser-157 on
Axin caused a significant increase of cells with multi-centrosomes,
consistent with a role of PLK1 in proper centrosome formation
and chromosome segregation [21].
Same as DNA replication, centrosomes are licensed to duplicate
once per cell cycle to ensure genetic stability. The exact
mechanism for centrosome amplification in tumor cells is not
clearly understood, but extra-centrosomes could result from
defects in the control of the centrosome replication cycle, failure
in cytokinesis or cell fusion. In our study, the appearance of extra-
centrosomes is more obvious in mitotic cells than in interphase
cells, indicating that altered centrosome replication cycle could be
the primary cause of multi-centrosome formation. The post-
translational modifications of the pericentriolar component c-
Figure 3. Axin phosphorylation by PLK1 regulates Axin-c-tubulin association. (A) Axin interacts with c-tubulin at its endogenous level. (B)
Axin-S157A and Axin-3SA show a sustained interaction with c-tubulin. HEK293T cells were transfected as indicated. TCLs and Axin
immunoprecipitates were subjected to immunoblotting as indicated.
doi:10.1371/journal.pone.0049184.g003
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Figure 4. Co-expression of PLK1 abolishes Axin-c-tubulin co-localization. (A) GFP-Axin-WT or GFP-Axin-S157A was co-transfected with
empty vector, FLAG-PLK1-WT or FLAG-PLK1-DN into HeLa cells. Cells were fixed and immuno-stained as described in Materials and Methods. Axin was
visualized by GFP, PLK1 by using anti-FLAG (red), c-tubulin by using anti-c-tubulin (pink), and nuclei by DAPI staining. (B) Bar chart showing the
quantification data for the co-localization rates between c-tubulin and GFP-Axin-WT or GFP-Axin-S157A at c-tubulin foci in the background of FLAG-
PLK1 or FLAG-PLK1-DN overexpression as shown in (A). n= 30 (‘‘n’’ indicates the number of the cells quantified), N.S.: not significant; **P,0.01
(ANOVA followed by tukey). (C) The centrosome region was circled and analyzed using Volocity software. The co-localization rate was analyzed
between 488 channel (Axin) and 642 channel (c-tubulin). Statistical analysis was performed as in (B). (D) FLAG-PLK1-WT and FLAG-PLK1-DN were
transfected respectively into HeLa cells. Goat anti-Axin, mouse anti-FLAG and rabbit anti-c-tubulin were used for staining of endogenous Axin, PLK1
and c-tubulin, respectively. The intensity of endogenous Axin and c-tubulin staining along the c-tubulin foci is shown by line profiles. A 2 mm line is
drawn along the centrosome region and the Y axis shows the intensity of 488 channel (Axin) and 642 channel (c-tubulin) along the distance of the
line (X axis).
doi:10.1371/journal.pone.0049184.g004
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Figure 5. Altered centrosome number in Axin-S157A expressing mitotic cells. (A) HeLa cells were transfected with GFP-Axin-S157A. Cells
were treated with thymidine-nocodazole, then fixed and stained as described in Materials and Methods. GFP staining for Axin, anti-a-tubulin staining
for microtubule (red), anti-pericentrin staining for centrosome (pink), and nuclear staining by DAPI were performed. (B) Bar chart representing the
percentage of the interphase or mitotic HeLa cells with multiple centrosomes. Cells were transfected with GFP vector (control), GFP-Axin-WT or GFP-
Axin-S157A mutant. ‘‘n’’ indicates the number of the mitotic cells quantified. The differences among interphase groups are not significant, P=0.528;
the differences among mitosis groups are significant (P=0.014, Vectora; Axin-WTa,b; Axin-S157Ab, Chi-Square Tests). (C) Centrosome numbers are not
altered in Axin-WT or Axin-S157A expressing interphase cells. HeLa cells were transfected with FLAG-Axin-WT or FLAG-Axin-S157A. Axin was
visualized by using anti-FLAG (red), pericentrin by anti-pericentrin (green), and nuclei by DAPI staining. (D) Axin-S157A overexpression delays the
chromosome segregation. The cells were synchronized at metaphase and released in fresh medium followed by staining with DAPI.
doi:10.1371/journal.pone.0049184.g005
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tubulin have been reported to be critically important for the
proper duplication of the centrosomes and the maintenance of an
appropriate centrosome number in the cell. c-tubulin should be
dynamically ubiquitinated and phosphorylated during centrosome
cycle. Specifically, non-ubiquitinable or phosphomimetic c-tubulin
mutants increase centrosome numbers, whereas un-phosphoryla-
table c-tubulin impaired centrosome duplication [22,23]. In view
of the dynamic phosphorylation of Axin, it would be expected that
the ubiquitination or phosphorylation status of c-tubulin is
regulated by Axin through its Ser-157 phosphorylation- status-
dependent interaction between these two proteins.
Correct number of centrosomes is critical for proper chromo-
some segregation during cell division and for the prevention of
aneuploidy, a hallmark of cancer [1–3]. However, recent studies
reveal a direct link between increased centrosome number and
cancer, in which extensive aneuploidy did not occur [24,25],
indicating that centrosome amplification itself may be sufficient to
promote tumor formation. In our study, the extra-centrosomes
observed in GFP-Axin-S157A transfected HeLa cells do not
possess the same microtubule nucleating ability, and the spindle
remained bi-polar. Hence these cells are not expected to become
aneuploid. However, these extra-centrosomes are not simply
innocent bystanders, whose appearance associates with a delay in
chromosome segregation in these cells (Figure 5D) and could lead
to other yet uncharacterized defects such as disruption of cell
polarity, interfering with normal cell behavior and tissue
architecture. The roles of these extra-centrosomes as well as the
fate of the cells with multi-centrosomes require further investiga-
tion and could provide insight into a new mechanism for tumor
formation and cancer development. It is intriguing to note that
another component in Wnt signaling, Dvl2, is also phosphorylated
by PLK1 [26]. Together with the report that PLK1 is
overexpressed in colorectal cancers, the majority of which are
characterized by dysregulated Wnt signalling [27], it is of interest
to test whether PLK1 plays a role in regulating Wnt/b-catenin
signalling in the future.
Materials and Methods
1. Plasmid constructions
Expression vectors for HA- or Myc-tagged wild-type mouse
Axin were constructed as previously described [14]. For the
construction of GFP-tagged wild-type Axin or its serine-to-alanine
mutants, wild type and mutants of Axin were digested internally at
NdeI and SmaI sites from pCMV5-HA-Axin, blunted with
Klenow fragment of pol I (Takara), gel purified, and inserted into
a SmaI digest of GFP-C1 vector. HA-, Myc-, FLAG-PLK1 were
generated by PCR amplification. PLK1 kinase-dead mutation was
created by site-directed mutagenesis using the TransformerTM site-
directed mutagenesis kit (CLONTECH). c-tubulin was amplified
from a human brain cDNA. All PCR products were verified by
sequencing. Sequences for all the oligonucleotides used in this
study are available upon request.
2. Cell culture, synchronization and transient transfection
HEK293T and HeLa cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS). To obtain M-phase arrested cells, HeLa cells
were incubated with the medium containing 2 mM thymidine for
24 h. The cells were then cultured with fresh medium for 3 h,
followed by incubation in fresh medium containing 200 ng/ml
nocodazole for additional 12 h. To arrest the cells in early-S-
phase, HeLa cells were treated with 2 mM thymidine for 18 h,
and were then changed to fresh medium for 9 h, followed by a
second treatment in the medium containing 2 mM thymidine for
17 h. Transfection was performed using Polyethylenimine.
3. Antibodies
Mouse anti-HA (F-7), anti-Myc (9E10) and goat anti-Axin1 (S-
20) were purchased from Santa Cruz Biotechnology. Mouse anti-
FLAG (M2), mouse anti-b-actin, mouse anti-a-tubulin, rabbit anti-
pericentrin and mouse anti-c-tubulin were purchased from Sigma.
Mouse anti-PLK1 (DR1037) was purchased from Calbiochem.
Rabbit anti-FLAG was purchased from Cell Signaling Technol-
ogy. Rabbit anti-phosH3 was purchased from Abcam. The
polyclonal antibody against Axin (C2b) was described previously
[15].
4. CIP assay
In brief, Axin proteins were immunoprecipitated, washed with
lysis buffer twice and then the phosphatase buffer twice. The
immunoprecipitates were then treated with calf intestinal phos-
phatase (CIP) in the assay buffer at 37uC for 30 min and the
reaction was stopped with 26SDS sample buffer.
5. In vitro phosphorylation of Axin
Kinase (wild-type and kinase-dead PLK1) and substrates (Axin
proteins) were purified from HEK293T cells. 500 mg of protein
lysates from HEK293T cells at 24 h post-transefection was used
for immunoprecipitation of FLAG-PLK1 or HA-Axin for 4 h with
FLAG or HA antibodies separately. The immunoprecipitates were
washed three times with lysis buffer and twice with kinase buffer,
and the FLAG-PLK1 was then eluted with 0.2 mg/ml M2 FLAG
peptide (Sigma-Aldrich). To start the kinase reaction, kinase and
substrate were incubated in 20 ml of kinase buffer (25 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 2 mM dithiothre-
itol, 5 mM b-glycerophosphate) supplemented with 50 mM ATP,
5 mCi of [c-32P] ATP incubated at 30uC for 30 min. Reactions
were terminated by adding an equal volume of 26SDS sample
buffer. The samples were separated on SDS-PAGE and analyzed
by Coomassie Blue staining and then dried prior to autoradiog-
raphy.
6. PLK1 siRNA
The N19 sequence targeting PLK1 is: 59-GGGCGGCTTT-
GCCAAGTG-39. Knockdown of PLK1 was mediated by lentivirus
infection system. Briefly, the virus carrying pLL3.7-PLK1 was
prepared by transfecting HEK293T cells with pLL3.7-PLK1,
pVSVG, pMDL and pREV. 24 h post-transfection, medium
containing virus was collected and added into the culture medium
of HeLa cells. At 24 h post-infection, HeLa cells were subcultured
and kept in DMEM containing 100 mg/ml G418.
7. Immunofluorescence staining and imaging analyses
HeLa cells grown on coverslips in 6-well plates were transfected
with indicated plasmids. After 24 h, cells were washed with PBS
twice, fixed in methanol for 10 min at 220uC, and incubated in
0.5% Triton-X-100 for 10 min followed by blocking in 5% BSA
for 1 h. Cells were then incubated for 1 h with primary antibodies
at room temperature. After being washed five times with PBS, cells
were incubated with Texas Red-conjugated goat anti-rabbit IgG
or Cy5-conjugated goat anti-mouse IgG for 1 h. Cells were
visualized under a Zeiss 510 META fluorescence confocal
microscope (Zeiss).
The line profile was generated using Image pro-plus 6 software.
A 2 mm line was draw along centrosome region. The intensities of
488 channel and 642 channel were shown in the graph. The X
Phosphorylation of Axin by PLK1
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axis indicates the localization along the line. The Y axis indicates
the localization pattern of the two channels—488 channel (Axin)
and 642 channel (c-tubulin).
To analyze co-localization rate of Axin and c-tubulin, the c-
tubulin positive foci were circled and analyzed using Volocity
software.
Supporting Information
Figure S1 GFP protein did not colocalize with c-tubulin.
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